Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > The Only Clock I'm Punching Is Algernon's Right In The Face.
View:
Post by C10H12N2 on Jun 29, 2022 2:50am

The Only Clock I'm Punching Is Algernon's Right In The Face.

The Effect Of Conducting A Gold Standard Chronic Cough Study In The USA

Comment by C10H12N2 on Jun 29, 2022 4:58am
Follow up post: Ifenprodil for IPF and Chronic Cough has always been Algernon's strongest drug candidate since its purchase from Nash Pharmaceuticals back in 2018. It was considered to be 10% of the total value of the purchase not including handing over 50% of Algernon to Nash Pharmaceuticals in the reverse takeover. followed up with massive dilution. Now the company has come to another ...more